• SENSEX 73,852.90
    -876.37 (--1.17%)
  • BANKNIFTY 55,488.10
    -355.90 (--0.64%)
  • Bharti Airtel
    1,865.00 1,726.05(%)
  • Anand Rathi Wea.
    2,170.90 2,267.00(%)
  • Reliance Industries
    1,201.10 1,152.30(%)
  • PC Jeweller
    18.64 18.64(%)
  • NSE
    1,725.00 1,712.00(%)
  • Gallantt Ispat L
    679.00 946.70(%)
  • Just Dial
    802.00 838.00(%)
  • ICICI Bank
    1,378.05 1,187.55(%)
  • Apollo Hospitals
    7,675.45 6,680.00(%)
  • Coal India
    412.00 369.55(%)
  • TCS
    2,432.00 1,976.00(%)
  • HDFC Bank
    707.40 682.00(%)
  • Infosys
    1,125.50 980.30(%)
  • Gland Pharma
    3,001.40 1,575.00(%)
  • Axis Bank
    1,225.00 1,150.50(%)
  • Federal Bank
    355.50 364.95(%)
  • Vedanta Aluminium Metal
    376.85 538.00(%)
  • Cupid
    334.20 45.40(%)
  • Max Healthcare
    828.25 828.25(%)
  • Le Travenues
    165.95 335.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Viyash Scientific Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • MNC Associate
  • BSE Code : 2086.0
  • ISIN : INE807F01027
221.11 -5 (-2.16%)
  • As on 20 Oct 2026 (EOD)

  • Today’s Low

    218.41

  • Today’s High

    229.19

  • Open

    229.19

  • Perv Close

    226.00

  • 52W Low

    178.13

  • 52W High

    298.00

Key Indicators

  • P/E(TTM)

    114.53

  • Mar.Cap (₹Cr.)

    9,767.83

  • Div & Yield %

    0.00

  • Book Value(₹)

    70.11

  • Debt-Equity Ratio

    -2.16

  • AGM Date

    19-Oct-2026

  • EPS

    1.93

  • P/E Ratio

    114.53

Financials Ratios

  • Debt-Equity Ratio

    0.69

  • Mar.Cap (₹Cr.)

    9,767.83

  • RONW (%)

    -3.09

  • ROCE (%)

    0.45

Score Board

  • Equity (₹ in Cr.)

    88.35

  • BV (₹)

    70.10

  • Sales( ₹ in Cr.)

    1,382.06

  • NP (in Cr.)

    104.50

  • NP Var(%)

    15.0

  • Div%

    0.0

  • CPS (₹)

    5.20

  • EPS (₹)

    2.40

  • Traded Value (₹ in Lakhs)

    9,765.18

  • 52 Week High

    298.00

  • 52 Week Low

    178.13

  • Price BSE

    221.0

  • Price NSE

    221.00

  • Market Capital( in Cr.)

    9,765.18

  • P/C Ratio

    42.70

  • P/E Ratio

    93.40

  • Price Vs.BV

    2.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 1,382.06 1,310.34 168.52 222.69 219.63 265.46
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,382.06 1,310.34 168.52 222.69 219.63 265.46
Other Income 66.26 72.59 45.98 28.24 27.64 19.97
Stock Adjustments 4.36 8.61 -5.35 -19.42 19.73 15.56
Total Income 1,452.68 1,391.54 209.15 231.51 267.00 300.99
EXPENDITURE :            
Raw Materials 628.23 599.56 102.54 116.50 128.39 124.43
Power and Fuel Cost 83.50 79.28 12.89 13.93 11.96 12.77
Employee Cost 213.75 215.85 30.05 36.66 27.38 22.42
Other Manufacturing Expenses 124.79 119.71 21.26 41.54 52.53 57.73
Selling and Administration Expenses 89.84 78.94 17.86 19.49 19.40 20.27
Miscellaneous Expenses 55.98 99.18 11.49 1.52 0.45 10.68
Employee Benefit Expenses 213.75 215.85 30.05 36.66 27.38 22.42
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,196.10 1,192.52 196.09 229.63 240.11 248.29
Operating Profit 256.58 199.02 13.06 1.88 26.89 52.70
Interest 16.21 25.14 4.36 2.51 1.61 2.68
Gross Profit 240.37 173.88 8.70 -0.63 25.28 50.02
Depreciation 124.15 124.72 8.94 9.12 9.59 9.13
Profit Before Tax 116.22 49.16 -0.24 -9.75 15.69 40.89
Current Tax 15.21 39.69 0.46 -0.57 0.37 6.09
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 25.14 -49.01 -1.32 -3.09 0.52 2.69
Reported Net Profit 75.87 58.49 0.62 -6.08 14.80 32.11
Extraordinary Items -28.63 -32.49 -1.69 0.00 0.00 -0.75
Adjusted Net Profit 104.50 90.98 2.31 -6.08 14.80 32.86
Adjustment below Net Profit -0.97 -0.44 2.65 0.09 0.07 43.38
P & L Balance brought forward -438.92 -490.47 38.76 30.56 28.03 -47.47
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 6.49 0.00 -14.19 12.34 0.00
P & L Balance carried down -364.02 -438.92 42.03 38.76 30.56 28.03
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 25.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.50
Earnings Per Share-Unit Curr 1.74 2.34 0.02 -0.24 0.60 1.29
Earnings Per Share(Adj)-Unit Curr 1.74 2.34 0.02 -0.24 0.60 1.29
Book Value 70.88 116.20 43.59 42.43 41.55 41.45
Book Value(Adj)-Unit Curr 70.88 116.20 43.59 42.43 41.55 41.45

Shareholding Pattern

  • Promoter Group

    49.24%

  • Public Share Holding

    50.66%

  • Custodian

    0.09%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 217,474,487 217,474,487.00 217,474,487 217,474,487
Sub Total 217,474,487 49.24 217,474,487 2
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 13 0.00 13 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 11,479,602 2.60 11,479,602 32
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 31,489,208 7.13 31,489,208 9
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 5,169,808 1.17 5,169,808 22
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 48,138,631 10.90 48,138,631 64
2] Non Institution
Bodies Corporate 27,181,417 6.15 27,181,417 1,021
Clearing Members 1,634 0.00 1,634 3
Directors of their Relatives 0 0.00 0 0
Employees 2,530,244 0.57 2,530,244 96
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 7,680,564 1.74 7,680,564 3,034
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 4,421,089 1.00 4,421,089 2,540
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 41,836,743 9.47 41,836,743 90
Individuals holding nominal share capital up to Rs. 1 lakh 76,248,582 17.27 76,223,577 135,871
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 2,353 0.00 2,353 4
Others 15,699,676 3.55 15,699,676 6
Sub Total 175,602,302 39.76 175,577,297 142,665
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 412,250 0.09 412,250 1
Total Shares held by Custodians and against which Depository Receipts have been issued 412,250 0.09 412,250 1
Grand Total ( A + B + C ) 441,627,670 100.00 441,602,665 142,732

Company Background

Viyash Scientific LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Viyash Scientific Ltd
  • BSE Code : 2086.0
  • ISIN : INE807F01027

  • Incorporation Year

    1985

  • Registered Office

    301 Dosti Pinnacle 3rd Floor
    Plot E7 Road No 22 Wagle Indl, Thane,
    Maharashtra-400604

  • Telephone

    91-022-41114777

  • FAX

    91-022-41114754

  • Chairman

    Kamal K Sharma

  • Managing Director

  • Company Secretary

    YOSHITA SUSMIT VORA

  • Auditor

    SRBC & Co LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Viyash Scientific Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Viyash Scientific 221.05 1,448.32 1,382.06 122.81 4.92
Abbott India 25,840.75 7,217.19 6,929.05 34.01 43.78
Astrazeneca Phar 6,043.30 2,304.07 2,275.58 89.07 27.86
Glaxosmi. Pharma 2,489.70 3,932.76 3,790.20 39.77 58.17
Novartis India 1,922.90 393.10 354.33 48.56 15.94
Cipla 1,331.00 20,102.60 18,979.95 34.98 13.88
Bliss GVS Pharma 631.20 773.53 729.81 58.66 12.51
Amrutanjan Healt 499.60 520.13 502.55 26.76 24.16
Fermenta Biotec. 459.40 474.15 450.25 21.45 18.77
Guj. Themis Bio. 359.10 168.25 165.82 96.02 18.05
Ambalal Sarabhai 38.82 19.52 3.94 71.89 6.77